284 related articles for article (PubMed ID: 15286961)
1. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer.
Fountoulakis A; Zafirellis KD; Dolan K; Dexter SP; Martin IG; Sue-Ling HM
Br J Surg; 2004 Aug; 91(8):997-1003. PubMed ID: 15286961
[TBL] [Abstract][Full Text] [Related]
2. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
3. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
4. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
[TBL] [Abstract][Full Text] [Related]
5. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.
Sujendran V; Sica G; Warren B; Maynard N
Eur J Cardiothorac Surg; 2005 Nov; 28(5):763-6. PubMed ID: 16188449
[TBL] [Abstract][Full Text] [Related]
6. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
7. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
8. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
11. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
[TBL] [Abstract][Full Text] [Related]
12. Changing patterns and surgical results in adenocarcinoma of the oesophagus.
Thomas P; Doddoli C; Lienne P; Morati N; Thirion X; Garbe L; Giudicelli R; Fuentes P
Br J Surg; 1997 Jan; 84(1):119-25. PubMed ID: 9043475
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
14. Early adenocarcinoma in Barrett's oesophagus.
Hölscher AH; Bollschweiler E; Schneider PM; Siewert JR
Br J Surg; 1997 Oct; 84(10):1470-3. PubMed ID: 9361616
[TBL] [Abstract][Full Text] [Related]
15. Outcome of endoscopy surveillance for Barrett's oesophagus.
Bright T; Schloithe A; Bull JA; Fraser RJ; Bampton P; Watson DI
ANZ J Surg; 2009 Nov; 79(11):812-6. PubMed ID: 20078532
[TBL] [Abstract][Full Text] [Related]
16. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
18. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS
J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
[TBL] [Abstract][Full Text] [Related]
20. A survey of oesophageal cancer: pathology, stage and clinical presentation.
Schlansky B; Dimarino AJ; Loren D; Infantolino A; Kowalski T; Cohen S
Aliment Pharmacol Ther; 2006 Mar; 23(5):587-93. PubMed ID: 16480397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]